Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Hepatolenticular Degeneration
- Study Comparing Once Daily Dose of 900mg of TETA 4HCL Against Cuprior® (450mg Trientine Base, Twice Daily).
- Pharmacokinetic Study of Oral ALXN1840 in Japanese and Non-Japanese Adult Healthy Participants
- Gandouling in the Treatment of Wilson's Disease
- Study of ALXN1840 Versus Standard of Care in Pediatric Participants With Wilson Disease
- Clinical Study of UX701 AAV-Mediated Gene Transfer for the Treatment of Wilson Disease
- Copper and Molybdenum Balance in Participants With Wilson Disease Treated With ALXN1840
- Study of ALXN1840 on the Metabolism of a CYP2B6 Substrate in Healthy Participants
- Phase 1 Study of ALXN1840 on the Metabolism of a CYP2C9 Substrate in Healthy Participants.
- Copper Concentration and Histopathologic Changes in Liver Biopsy in Participants With Wilson Disease Treated With ALXN1840
- The Individual Therapy for Patients With Wilson's Disease
- Trientine Tetrahydrochloride (TETA 4HCL) for the Treatment of Wilson's Disease
- Efficacy and Safety of ALXN1840 (Formerly Named WTX101) Administered for 48 Weeks Versus Standard of Care in Participants With Wilson Disease With an Extension Period of up to 60 Months
- sCD163 and sMR in Wilsons Disease - Associations With Disease Severity and Fibrosis
- Study to Assess Long-Term Outcomes of Trientine in Wilson Disease Patients Withdrawn From Therapy With d-Penicillamine
- Efficacy and Safety Study of WTX101 (ALXN1840) in Adult Wilson Disease Patients
- A Phase 1 Study to Assess the Effects in the Body of a Single Dose of Trientine Dihydrochloride in Wilson's Disease Patients
- Single Daily Dosage of Trientine for Maintenance Treatment for Wilson Disease
- Efficacy and Safety Study of Zinc Acetate to Treat Wilson's Disease in Japan.
- Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan.
- Study of Tetrathiomolybdate in Patients With Wilson Disease
- Study of Zinc for Wilson Disease